- Home
- PMVP vs AKYA Comparison
PMVP vs AKYA Comparison
Compare PMVP & AKYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- AKYA
- Stock Information
- Founded
- PMVP 2013
- AKYA 2015
- Country
- PMVP United States
- AKYA United States
- Employees
- PMVP N/A
- AKYA N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- AKYA Medical Specialities
- Sector
- PMVP Health Care
- AKYA Industrials
- Exchange
- PMVP Nasdaq
- AKYA Nasdaq
- Market Cap
- PMVP 55.1M
- AKYA 56.1M
- IPO Year
- PMVP 2020
- AKYA 2021
- Fundamental
- Price
- PMVP $1.09
- AKYA $1.26
- Analyst Decision
- PMVP Strong Buy
- AKYA Hold
- Analyst Count
- PMVP 1
- AKYA 7
- Target Price
- PMVP $5.00
- AKYA $2.51
- AVG Volume (30 Days)
- PMVP 362.7K
- AKYA 265.5K
- Earning Date
- PMVP 08-07-2025
- AKYA 08-04-2025
- Dividend Yield
- PMVP N/A
- AKYA N/A
- EPS Growth
- PMVP N/A
- AKYA N/A
- EPS
- PMVP N/A
- AKYA N/A
- Revenue
- PMVP N/A
- AKYA $79,961,000.00
- Revenue This Year
- PMVP N/A
- AKYA $7.26
- Revenue Next Year
- PMVP N/A
- AKYA $11.44
- P/E Ratio
- PMVP N/A
- AKYA N/A
- Revenue Growth
- PMVP N/A
- AKYA N/A
- 52 Week Low
- PMVP $0.81
- AKYA $0.93
- 52 Week High
- PMVP $1.82
- AKYA $3.42
- Technical
- Relative Strength Index (RSI)
- PMVP 61.16
- AKYA 52.71
- Support Level
- PMVP $1.01
- AKYA $1.21
- Resistance Level
- PMVP $1.12
- AKYA $1.35
- Average True Range (ATR)
- PMVP 0.07
- AKYA 0.08
- MACD
- PMVP 0.01
- AKYA 0.01
- Stochastic Oscillator
- PMVP 64.00
- AKYA 60.71
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.